Mustang Bio Announces Positive Opinion from the European Medicines Agency on Orphan Drug Designation for Its Lentiviral Gene Therapy for the Treatment of X-linked Severe Combined Immunodeficiency (“XSCID”)

Frank Burrell
Scientific Storytelling

Liz Kane
Impactful Strategy

Bud Bilanich
Success Coach

Matt Turner
Patient Affordability

Amy Giles
Increasing Engagement

Brenda Snow
Authentic Patient Voice

Daniel Sontupe
Market Access

Paul Theisen
Patient Acquisition

Suma Ramadas, PhD
Medical Affairs

David Linetsky
Point-of-Care Marketing

Joey Cohen
Medication Adherence

Pat Purcell
Meeting Engagement

Stacey Gandler
Brand Nourishment

Matthew Durham
Omnidynamic Marketing